Gallic Acid Is an Antagonist of Semen Amyloid Fibrils That Enhance HIV-1 Infection
Open Access
- 1 July 2016
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (27) , 14045-14055
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R21GM101134, 5T32GM067545)
- National Institute of Allergy and Infectious Diseases (R00AI104262, R21AI120774, P30-AI027763)
This publication has 49 references indexed in Scilit:
- Site Specific Interaction of the Polyphenol EGCG with the SEVI Amyloid Precursor Peptide PAP(248–286)The Journal of Physical Chemistry B, 2012
- Oligovalent Amyloid-Binding Agents Reduce SEVI-Mediated Enhancement of HIV-1 InfectionJournal of the American Chemical Society, 2011
- Peptides Released by Physiological Cleavage of Semen Coagulum Proteins Form Amyloids that Enhance HIV InfectionCell Host & Microbe, 2011
- Amyloid-binding Small Molecules Efficiently Block SEVI (Semen-derived Enhancer of Virus Infection)- and Semen-mediated Enhancement of HIV-1 InfectionJournal of Biological Chemistry, 2010
- Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced ToxicityJournal of Biological Chemistry, 2010
- Identifying the amylome, proteins capable of forming amyloid-like fibrilsProceedings of the National Academy of Sciences, 2010
- Aminoquinoline Surfen Inhibits the Action of SEVI (Semen-derived Enhancer of Viral Infection)Journal of Biological Chemistry, 2010
- The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infectionProceedings of the National Academy of Sciences, 2009
- The Cationic Properties of SEVI Underlie Its Ability To Enhance Human Immunodeficiency Virus InfectionJournal of Virology, 2009
- Whither or Wither Microbicides?Science, 2008